Resolvin E1/E2 ameliorate lipopolysaccharide-induced depression-like behaviors via ChemR23-Reference-Cited by-同舟云学术

Resolvin E1/E2 ameliorate lipopolysaccharide-induced depression-like behaviors via ChemR23

Published:2017-10-31 Issue:1 Volume:235 Page:329-336
ISSN:0033-3158
Container-title:Psychopharmacology
language:en
Short-container-title:Psychopharmacology

Author:

Deyama Satoshi,Shimoda Kento,Suzuki Hiroe,Ishikawa Yuka,Ishimura Kohei,Fukuda Hayato,Hitora-Imamura Natsuko,Ide Soichiro,Satoh Masamichi,Kaneda Katsuyuki,Shuto Satoshi,Minami Masabumi

Funder

Japan Society for the Promotion of Science (JP)

Uehara Memorial Foundation

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology

Link

http://link.springer.com/article/10.1007/s00213-017-4774-7/fulltext.html

Reference36 articles.

1. Aguilar-Valles A, Kim J, Jung S, Woodside B, Luheshi GN (2014) Role of brain transmigrating neutrophils in depression-like behavior during systemic infection. Mol Psychiatry 19:599–606

2. Arita M, Bianchini F, Aliberti J, Sher A, Chiang N, Hong S, Yang R, Petasis NA, Serhan CN (2005) Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J Exp Med 201:713–722

3. Arita M, Ohira T, Sun YP, Elangovan S, Chiang N, Serhan CN (2007) Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation. J Immunol 178:3912–3917

4. Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW (2008) From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9:46–57

5. Deyama S, Ishikawa Y, Yoshikawa K, Shimoda K, Ide S, Satoh M, Minami M (2017) Resolvin D1 and D2 reverse lipopolysaccharide-induced depression-like behaviors through the mTORC1 signaling pathway. Int J Neuropsychopharmacol 20:575–584

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Resolution of inflammation, an active process to restore the immune microenvironment balance: A novel drug target for treating arterial hypertension;Ageing Research Reviews;2024-08

2. Resolvin E1 as a potential lead for the treatment of depression;Folia Pharmacologica Japonica;2024-07-01

3. Is Lipid Metabolism of Value in Cancer Research and Treatment? Part II: Role of Specialized Pro-Resolving Mediators in Inflammation, Infections, and Cancer;Metabolites;2024-05-29

4. Adipocytokines levels as potential biomarkers for discriminating patients with a diagnosis of depressive disorder from healthy controls;Journal of Psychiatric Research;2024-03

5. Structural basis of G protein–Coupled receptor CMKLR1 activation and signaling induced by a chemerin-derived agonist;PLOS Biology;2023-12-06